[go: up one dir, main page]

UY35343A - Formulaciones y procedimientos para la producción de proteína recombinante aumentada - Google Patents

Formulaciones y procedimientos para la producción de proteína recombinante aumentada

Info

Publication number
UY35343A
UY35343A UY0001035343A UY35343A UY35343A UY 35343 A UY35343 A UY 35343A UY 0001035343 A UY0001035343 A UY 0001035343A UY 35343 A UY35343 A UY 35343A UY 35343 A UY35343 A UY 35343A
Authority
UY
Uruguay
Prior art keywords
formulations
procedures
production
increased
recombining
Prior art date
Application number
UY0001035343A
Other languages
English (en)
Inventor
Shimoni Yuval
Möhrle Dr Volker
Srinivasan Venkatesh
Matanguihan Ricaredo
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of UY35343A publication Critical patent/UY35343A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se divulgan formulaciones y procedimientos para incrementar la producción de proteínas recombinantes, y otros aspectos. Las formulaciones y los procedimientos se refieren al aumento de la concentración de manosa o calcio, o ambos, en una formulación de medio de cultivo celular para cultivar células que expresan proteínas recombinantes
UY0001035343A 2013-02-26 2014-02-21 Formulaciones y procedimientos para la producción de proteína recombinante aumentada UY35343A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361769402P 2013-02-26 2013-02-26

Publications (1)

Publication Number Publication Date
UY35343A true UY35343A (es) 2014-09-30

Family

ID=50240092

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035343A UY35343A (es) 2013-02-26 2014-02-21 Formulaciones y procedimientos para la producción de proteína recombinante aumentada

Country Status (18)

Country Link
US (2) US20160002592A1 (es)
EP (1) EP2961827A1 (es)
JP (1) JP2016508376A (es)
KR (1) KR20150121701A (es)
CN (1) CN105308174A (es)
AR (1) AR094875A1 (es)
AU (1) AU2014223680A1 (es)
BR (1) BR112015020253A2 (es)
CA (1) CA2902170A1 (es)
EA (1) EA201591558A1 (es)
HK (1) HK1220991A1 (es)
IL (1) IL240639A0 (es)
MX (1) MX2015010887A (es)
PE (1) PE20152019A1 (es)
SG (1) SG11201506212PA (es)
TW (1) TW201522634A (es)
UY (1) UY35343A (es)
WO (1) WO2014134071A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
EP3409783B1 (de) * 2017-06-01 2020-12-16 Justus-Liebig-Universität Gießen Erfindung betreffend detektion und quantifizierung von colistin-resistenz bei gram-negativen bakterien
CN112006522B (zh) * 2019-05-31 2022-01-28 佛山市顺德区美的电热电器制造有限公司 烹饪器具、用于烹饪器具的烹饪附件以及控制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238891B1 (en) * 1987-11-18 2001-05-29 Cetus Oncology Corporation Method of increasing product expression through solute stress
EP0592692B1 (en) * 1992-05-01 1997-07-02 Teijin Limited Fed batch process for protein secreting cells
EP1844068A4 (en) * 2005-01-25 2009-09-30 Apollo Life Sciences Ltd MOLECULES AND THEIR CHIMERIC MOLECULES
CN101198621A (zh) * 2005-01-25 2008-06-11 阿波罗生命科学有限公司 分子及其嵌合分子
DE102005046225B4 (de) * 2005-09-28 2012-01-05 Cellca Gmbh Verbessertes Zellkulturmedium
CN101675339B (zh) * 2007-04-16 2014-04-16 动量制药公司 涉及细胞表面糖基化作用的方法
GB0915481D0 (en) * 2009-09-04 2009-10-07 Arecor Ltd Stable manufacture of factor V111
US8969304B2 (en) * 2010-04-09 2015-03-03 The Institute For Cancer Research Compositions and methods for the prevention of cancer in high risk patients
US9458222B2 (en) * 2010-07-08 2016-10-04 Baxalta Incorporated Method of producing recombinant ADAMTS13 in cell culture
CN102971006A (zh) * 2010-07-15 2013-03-13 诺沃—诺迪斯克有限公司 稳定的因子viii变体

Also Published As

Publication number Publication date
MX2015010887A (es) 2015-12-01
PE20152019A1 (es) 2016-01-29
US20160002592A1 (en) 2016-01-07
CA2902170A1 (en) 2014-09-04
WO2014134071A1 (en) 2014-09-04
EA201591558A1 (ru) 2016-03-31
SG11201506212PA (en) 2015-09-29
EP2961827A1 (en) 2016-01-06
HK1220991A1 (zh) 2017-05-19
AR094875A1 (es) 2015-09-02
AU2014223680A1 (en) 2015-09-17
IL240639A0 (en) 2015-09-24
CN105308174A (zh) 2016-02-03
BR112015020253A2 (pt) 2017-07-18
JP2016508376A (ja) 2016-03-22
TW201522634A (zh) 2015-06-16
US20180010090A1 (en) 2018-01-11
KR20150121701A (ko) 2015-10-29

Similar Documents

Publication Publication Date Title
CY1121934T1 (el) Αντισωματα anti-fcrn
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
CY1123142T1 (el) Βελτιωμενες μεθοδοι για την παραγωγη θετων κυτταρικων θεραπειων
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
CY1125392T1 (el) Συνθεσεις και μεθοδοι γλυζυλιωσης πρωτεϊνων
EA202090931A2 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
EA201590488A1 (ru) Способы модификации клеток-хозяев
AR095437A1 (es) Proteínas de fusión comprendiendo porciones pdgf y vegf de unión y métodos para su uso
AR105602A1 (es) Medio de cultivo celular suplementado con taurina y métodos de utilización
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
CR20140586A (es) Celulas para producir iduronato-2-sulfatasa recombinante
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
FI20106121L (fi) Soluviljelymateriaali
BR112016023304A2 (pt) célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares
EA201500172A1 (ru) Модифицированные полипептиды фактора х и их применение
EA201391041A1 (ru) Растворимые в воде мембранные белки и способы их получения и применения
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
CL2012003075A1 (es) Composicion farmaceutica en solucion de pazopanib, estable y para uso oftalmico; metodo para la preparacion de dicha solucion.
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
CR20140587A (es) Metodo para producir iduronato-2-sulfatasa recombinante
MX2015012168A (es) Expansión de celulas madre adultas in vitro.
AR092879A1 (es) Proteinas de fusion de g3p como agentes de union a amiloide
EA201791918A1 (ru) Модификация белков клеток-хозяев
EA201501028A1 (ru) Конструкции митохондриальных белков и их применение

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211110